Yan Moore - Jan 31, 2022 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
Chief Medical Officer
Signature
/s/ Barbara Chan as Attorney-in-Fact for Yan Moore
Stock symbol
OMGA
Transactions as of
Jan 31, 2022
Transactions value $
$0
Form type
4
Date filed
2/2/2022, 03:05 PM
Previous filing
Jan 6, 2022
Next filing
Oct 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Option (Right to Buy) Award $0 +478K $0.00 478K Jan 31, 2022 Common Stock 478K $11.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable as to 25% on January 3, 2023 and as to 6.25% of the underlying shares upon the Reporting Person's completion of each three full months of continued service to the Issuer thereafter, such that the option will be fully vested and exercisable on January 3, 2026.